A Survival Analysis of Pediatric Acute Lymphoblastic Leukemia in Morocco
Nada Bennani Mechita(Directorate of Health), Maria El Kababri(École des Hautes Études Commerciales), Siham Cherkaoui(Hôpital 20 Août), Latefa Belakhel(Directorate of Health), Amina Kili(École des Hautes Études Commerciales), Sara Benmiloud(Moroccan Foundation for Advanced Science, Innovation and Research), Ayad Ghanam(Mohamed I University), Noufissa Benajiba(Centre Hospitalo-Universitaire Mohammed VI d'Oujda), K. Maani(Hôpital 20 Août), Mhamed Harif(Institut d’Hématologie et d’Oncologie Pédiatrique), M. EL ALAOUI EL HANAFI(Hôpital 20 Août), Loubna Abouselham(Kementerian Kesehatan Republik Indonesia), Abdellah Madani(Hôpital 20 Août), Mohammed Khattab(Université Internationale Abulcasis des Sciences de la Santé), Jamila El Houdzi(Sup de Co Marrakech), Nissrine Khoubila(Hôpital 20 Août), Fatima Ezzahra Lahlimi(Cadi Ayyad University), Illias Tazi(Hôpital 20 Août), Mohammed Youbi(Ministère de la Santé), Laila Hessissen(Mohammed V University)
Cited by 0
Related Papers
Paediatric cancer in low-income and middle-income countries
|The Lancet Oncology|2013|432
The My Child Matters programme: effect of public–private partnerships on paediatric cancer care in low-income and middle-income countries
|The Lancet Oncology|2018|150
Treating Childhood Cancer in Low- and Middle-Income Countries
|Unknown|2015|146
Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study
|The Lancet Child & Adolescent Health|2021|134